Wed, September 14, 2022
Tue, September 13, 2022
Mon, September 12, 2022

John Lee Downgraded (ANAB) to Hold and Decreased Target to $28 on, Sep 13th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. and-decreased-target-to-28-on-sep-13th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
John Lee of Truist Securities, Downgraded "AnaptysBio, Inc." (ANAB) to Hold and Decreased Target from $50 to $28 on, Sep 13th, 2022.

John has made no other calls on ANAB in the last 4 months.



There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, 0 agree with John's Rating of Hold.



This is the rating of the analyst that currently disagrees with John


  • Steven Seedhouse of "Raymond James" Initiated at Buy and Held Target at $35 on, Thursday, September 1st, 2022